Xizhi, Taiwan

Ann Chen

This inventor holds 1 USPTO granted patent. Top assignee: Development Center for Biotechnology. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ann Chen. Retrieved from https://idiyas.com/inventor/ann-chen-jfkp539z

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ann Chen - Innovator in Nephritis Treatment

Introduction

Ann Chen is a prominent inventor based in Xizhi, Taiwan. She has made significant contributions to the field of nephrology through her innovative research and development. Her work focuses on creating effective treatments for nephritis, a condition that affects the kidneys.

Latest Patents

Ann Chen holds a patent for a method of treating nephritis. This invention relates to methods for treatment of nephritis and provides a unique approach by administering an herbal pharmaceutical composition. Specifically, her invention includes a composition comprising Rhizoma and Herba, which is effective in treating subjects afflicted with active nephritis. This patent highlights her commitment to integrating traditional herbal medicine with modern therapeutic practices.

Career Highlights

Ann Chen is associated with the Development Center for Biotechnology, where she collaborates with other researchers to advance biotechnological innovations. Her dedication to improving health outcomes through her inventions has positioned her as a key figure in her field.

Collaborations

Some of her notable coworkers include Shuk-Man Ka and Rey-Yuh Wu. Their collaborative efforts contribute to the ongoing research and development initiatives at the Development Center for Biotechnology.

Conclusion

Ann Chen's innovative work in nephritis treatment exemplifies the intersection of traditional medicine and modern science. Her contributions are paving the way for new therapeutic options for patients suffering from this condition.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…